Martin W. MacKay Ph.D.
Net Worth
Last updated:
What is Martin W. MacKay Ph.D. net worth?
The estimated net worth of Dr. Martin W. MacKay Ph.D. is at least $1,797,241 as of 11 Jan 2022. He owns shares worth $160,861 as insider and has received compensation worth at least $1,636,380 in Rallybio Corporation.
What is the salary of Martin W. MacKay Ph.D.?
Dr. Martin W. MacKay Ph.D. salary is $545,460 per year as Chief Executive Officer & Chairman in Rallybio Corporation.
How old is Martin W. MacKay Ph.D.?
Dr. Martin W. MacKay Ph.D. is 69 years old, born in 1956.
What stocks does Martin W. MacKay Ph.D. currently own?
As insider, Dr. Martin W. MacKay Ph.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Rallybio Corporation (RLYB) | Chief Executive Officer & Chairman | 282,609 | $0.57 | $160,861 |
What does Rallybio Corporation do?
Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT). The company is also developing RLYB211, a polyclonal anti-HPA-1a antibody that is in a Phase 1/2 clinical trial for the prevention of FNAIT; RLYB114, a pegylated complement factor 5 (C5)-targeted Affibody molecule in preclinical development for the treatment of complement-mediated ophthalmic diseases; and RLYB116, a subcutaneously administered inhibitor of C5 for the treatment of patients with paroxysmal nocturnal hemoglobinuria and generalized myasthenia gravis. Rallybio has collaboration with Exscientia for the development of small molecule therapeutics for rare diseases. Rallybio Corporation was founded in 2018 and is headquartered in New Haven, Connecticut.
Martin W. MacKay Ph.D. insider trading
Rallybio key executives
Rallybio Corporation executives and other stock owners filed with the SEC:
- Dr. Martin W. MacKay Ph.D. (69) Chief Executive Officer & Chairman
- Dr. Stephen Uden M.B, M.D. (67) Pres, Chief Operating Officer & Chief Scientific Officer
- Mr. Jeffrey M. Fryer CPA (56) Chief Financial Officer & Treasurer